-
Health Catalyst (HCAT) Reports In-Line Q3 EPS
-
Health Catalyst units earn HITRUST r2 security certifications
-
Cantor Fitzgerald Reiterates Neutral Rating on Health Catalyst Inc. (HCAT)
-
Health Catalyst Inc. (HCAT) PT Lowered to $5 at Canaccord Genuity
-
Health Catalyst Inc. (HCAT) PT Raised to $4 at Evercore ISI
-
Piper Sandler Downgrades Health Catalyst Inc. (HCAT) to Neutral
-
Health Catalyst Inc. (HCAT) PT Lowered to $6 at Wells Fargo
-
Cantor Fitzgerald Downgrades Health Catalyst Inc. (HCAT) to Neutral
-
Health Catalyst (HCAT) Misses Q2 EPS by 63c
-
Health Catalyst CEO Dan Burton to retire in June 2026
-
Cantor Fitzgerald Reiterates Overweight Rating on Health Catalyst Inc. (HCAT)
-
BTIG Downgrades Health Catalyst Inc. (HCAT) to Neutral
-
Stifel Reiterates Hold Rating on Health Catalyst Inc. (HCAT)
-
Health Catalyst Inc. (HCAT) PT Lowered to $9 at Canaccord Genuity
-
Health Catalyst Inc. (HCAT) PT Raised to $5 at Evercore ISI
-
Health Catalyst (HCAT) Tops Q1 EPS by 1c
-
Cantor Fitzgerald Reiterates Overweight Rating on Health Catalyst Inc. (HCAT)
-
Evercore ISI Downgrades Health Catalyst Inc. (HCAT) to In Line
-
Ardent Health (ARDT) appoints Robert DeMichiei to Board
-
Given contract opportunity Caid stocks likely undervalued, says Cantor Fitzgerald
-
William Blair on Health Catalyst Inc. (HCAT), 'We View Company as Underappreciated HCIT Asset'
-
Health Catalyst (HCAT) Announces ~$5 Million Stock Repurchase
-
Health Catalyst Inc. (HCAT) PT Lowered to $10 at BTIG
-
Health Catalyst (HCAT) Misses Q4 EPS by 40c
-
Health Catalyst Inc. (HCAT) PT Lowered to $8 at Piper Sandler amid 'Top-Line Drama'
-
Health Catalyst Inc. (HCAT) PT Lowered to $10 at Canaccord Genuity
-
Health Catalyst Inc. (HCAT) PT Lowered to $7 at RBC Capital
-
Health Catalyst (HCAT) to Acquire Upfront Healthcare Services
-
KeyBanc Upgrades Health Catalyst Inc. (HCAT) to Overweight
-
Health Catalyst Inc. (HCAT) PT Raised to $12 at Piper Sandler
-
Health Catalyst Inc. (HCAT) PT Raised to $9 at Stephens
-
Health Catalyst (HCAT) Misses Q3 EPS by 3c, provides guidance
-
Health Catalyst (HCAT) to Acquire Intraprise Health
-
Canaccord Genuity Reiterates Buy Rating on Health Catalyst Inc. (HCAT)
-
Health Catalyst Inc. (HCAT) PT Lowered to $11 at Piper Sandler
-
Health Catalyst Inc. (HCAT) PT Lowered to $7 at Stephens
-
Health Catalyst (HCAT) Tops Q2 EPS by 4c ; Offers Guidance
-
Health Catalyst (HCAT) Announces New Credit Facility for up to $225,000,000
-
Wells Fargo Reiterates Overweight Rating on Health Catalyst Inc. (HCAT)

